| Dr Kelsey L Jones, OD | |
|
10 E Merrick Rd, Valley Stream, NY 11580-5800 | |
| (516) 825-7455 | |
| Not Available |
| Full Name | Dr Kelsey L Jones |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 5 Years |
| Location | 10 E Merrick Rd, Valley Stream, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316509425 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 008992 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Stream Optometric Services Pc | 7719271162 | 2 |
| Vision For Life Corp | 5294794202 | 2 |
News Archive
Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.
During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
People admitted to NHS hospitals with a cardiac arrest over the weekend do not face a higher risk of dying compared to those admitted during the week, according to new research presented today at the British Cardiovascular Society Conference in Manchester.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
› Verified 3 days ago
| Provider Name | Empire Vision Center Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750358826 PECOS PAC ID: 4688573876 Enrollment ID: O20040107000405 |
News Archive
Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.
During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
People admitted to NHS hospitals with a cardiac arrest over the weekend do not face a higher risk of dying compared to those admitted during the week, according to new research presented today at the British Cardiovascular Society Conference in Manchester.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
› Verified 3 days ago
| Provider Name | Vision For Life Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679668727 PECOS PAC ID: 5294794202 Enrollment ID: O20120215000275 |
News Archive
Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.
During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
People admitted to NHS hospitals with a cardiac arrest over the weekend do not face a higher risk of dying compared to those admitted during the week, according to new research presented today at the British Cardiovascular Society Conference in Manchester.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
› Verified 3 days ago
| Provider Name | Valley Stream Optometric Services Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083060131 PECOS PAC ID: 7719271162 Enrollment ID: O20160808000491 |
News Archive
Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.
During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
People admitted to NHS hospitals with a cardiac arrest over the weekend do not face a higher risk of dying compared to those admitted during the week, according to new research presented today at the British Cardiovascular Society Conference in Manchester.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelsey L Jones, OD 10 E Merrick Rd, Valley Stream, NY 11580-5800 Ph: (516) 825-7455 | Dr Kelsey L Jones, OD 10 E Merrick Rd, Valley Stream, NY 11580-5800 Ph: (516) 825-7455 |
News Archive
Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.
During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
People admitted to NHS hospitals with a cardiac arrest over the weekend do not face a higher risk of dying compared to those admitted during the week, according to new research presented today at the British Cardiovascular Society Conference in Manchester.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
› Verified 3 days ago
South Shore Opticians Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1033 Green Acres Mall, Valley Stream, NY 11581 Phone: 516-825-8990 Fax: 516-872-2702 | |
Valley Stream Optometric Services Pc Optometrist Medicare: Medicare Enrolled Practice Location: 5 Sunrise Plz Ste 101, Valley Stream, NY 11580 Phone: 516-825-7455 Fax: 516-825-1494 | |
Brenda Liang, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 10 E Merrick Rd Ste 201, Valley Stream, NY 11580 Phone: 516-825-7455 Fax: 516-825-1494 | |
Dr. Arthur Michael Purvin, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 E. Merrick Rd., Suite 201, Valley Stream, NY 11580 Phone: 516-825-7455 Fax: 516-825-1494 | |
Dr. Mark Joel Bashover, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 845 Newburg Ave, Valley Stream, NY 11581 Phone: 516-791-8254 Fax: 516-791-8254 | |
Howard Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 129 Rockaway Ave, Valley Stream, NY 11580 Phone: 516-561-8545 | |
Cohen's Fashion Optical Optometrist Medicare: Medicare Enrolled Practice Location: 1112 Green Acres Mall, Valley Stream, NY 11581 Phone: 516-825-4900 Fax: 516-561-5905 |